Ashland vs Innospec
Ashland and Innospec are similar in size: $1.82bn and $1.78bn of revenue in their latest fiscal years. Innospec grew faster (-3.7% against -13.7%). Innospec kept more of each dollar of sales as profit: a net margin of 6.6% against -46.3%.
| Latest fiscal year | AshlandASH, 2025 | InnospecIOSP, 2025 |
|---|---|---|
| Revenue | $1.82bn | $1.78bn |
| Revenue growth | -13.7% | -3.7% |
| Net income | −$845m | $117m |
| Operating margin | — | 7.3% |
| Net margin | -46.3% | 6.6% |
| Return on equity | -35.4% | 9.2% |
| Free cash flow | $36.0m | $88.0m |
| Cash | $215m | $293m |
| Total debt | $1.39bn | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | $1.64 | $1.71 |
| Dividend yield | 2.2% | — |
| Share buybacks | $100m | $23.9m |
| Employees | 2,900 | 2,450 |
| Market value | $3.40bn | $2.49bn |
| Price vs our value range | Above our value range | Within our value range |
| Moat score | 46 (Moderate) | 62 (Moderate) |
| Insider trades, 12 months | 0 buys, 0 sales | 1 buys, 18 sales |